"ANP’s partner Strongbridge advised on 19th November 2015 in a corporate update that they werefrom Strongbridge on their progress and their development plans for COR-004."
engaging with regulatory agencies to determine future development plans for COR-004. They also
specified that they were pursuing orphan drug designation for COR-004. ANP are awaiting advice back
----------
•Request for an Orphan Drug Designation can be submitted at any time during pre-clinical or clinical development, as long as it is submitted prior to submission of the sponsor’s marketing application
–No Investigational New Drug Application (IND) is required
•Typical review cycle is approximately 60-90 days
•Will receive either:
–Designation Letter, OR
–Deficiency Letter
•Once designated, sponsor required to submit annual reports until drug is approved
•Deficiency letter response required within 1 year after issuance
-----------
Coming up to 3 months
-----------
I really wonder WTF they are doing??
- Forums
- ASX - By Stock
- PER
- Why Im excited!
Why Im excited!, page-59
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
-0.003(3.80%) |
Mkt cap ! $68.51M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.5¢ | $47.57K | 622.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1598 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 140942 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25032 | 0.079 |
1 | 1598 | 0.076 |
1 | 100000 | 0.075 |
1 | 69866 | 0.074 |
2 | 111973 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 140942 | 2 |
0.080 | 243231 | 2 |
0.081 | 198015 | 2 |
0.082 | 75174 | 2 |
0.083 | 93000 | 1 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |